Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Visa
V
|
+$55.5M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$35.4M |
| 3 |
International Paper
IP
|
+$25.3M |
| 4 |
DoorDash
DASH
|
+$21.9M |
| 5 |
Natera
NTRA
|
+$17.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$120M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$24.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 11.72% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
St. Joe Company
JOE
$3B
| $3.72M | ﹤0.01% |
79,200
-1,200
| -1% | -$56.3K |
|
1427
Cellebrite
CLBT
$4.31B
| $3.72M | ﹤0.01% |
191,300
+40,700
| +27% | +$791K |
|
1428
Fortuna Silver Mines
FSM
$2.42B
| $3.72M | ﹤0.01% |
610,830
-8,000
| -1% | -$48.7K |
|
1429
Skyward Specialty Insurance
SKWD
$1.93B
| $3.7M | ﹤0.01% |
69,900
+3,100
| +5% | +$164K |
|
1430
John Wiley & Sons Class A
WLY
$2.19B
| $3.7M | ﹤0.01% |
83,000
-1,300
| -2% | -$57.9K |
|
1431
Marriott Vacations Worldwide
VAC
$2.65B
| $3.7M | ﹤0.01% |
57,536
-800
| -1% | -$51.4K |
|
1432
Enlight Renewable Energy
ENLT
$3.77B
| $3.69M | ﹤0.01% |
231,048
-1,650
| -0.7% | -$26.3K |
|
1433
Century Communities
CCS
$2.02B
| $3.67M | ﹤0.01% |
54,666
-800
| -1% | -$53.7K |
|
1434
Liberty Global Class A
LBTYA
$4.08B
| $3.66M | ﹤0.01% |
318,100
-4,900
| -2% | -$56.4K |
|
1435
Hawaiian Electric Industries
HE
$2.09B
| $3.66M | ﹤0.01% |
334,100
+10,800
| +3% | +$118K |
|
1436
Rigetti Computing
RGTI
$8.14B
| $3.66M | ﹤0.01% |
+461,800
| New | +$3.66M |
|
1437
CONMED
CNMD
$1.58B
| $3.62M | ﹤0.01% |
59,900
-700
| -1% | -$42.3K |
|
|
TGI
1438
DELISTED
Triumph Group
TGI
| $3.61M | ﹤0.01% |
142,400
-2,100
| -1% | -$53.2K |
|
1439
Premier
PINC
$2.21B
| $3.59M | ﹤0.01% |
186,112
-11,000
| -6% | -$212K |
|
1440
Liberty Global Class C
LBTYK
$4.12B
| $3.58M | ﹤0.01% |
299,370
-12,800
| -4% | -$153K |
|
1441
Soleno Therapeutics
SLNO
$2.92B
| $3.58M | ﹤0.01% |
50,100
+4,200
| +9% | +$300K |
|
1442
OFG Bancorp
OFG
$1.98B
| $3.56M | ﹤0.01% |
89,000
-2,800
| -3% | -$112K |
|
1443
Select Medical
SEM
$1.55B
| $3.56M | ﹤0.01% |
213,200
-4,200
| -2% | -$70.1K |
|
1444
First Busey Corp
BUSE
$2.22B
| $3.56M | ﹤0.01% |
164,800
+53,001
| +47% | +$1.14M |
|
1445
NovoCure
NVCR
$1.44B
| $3.55M | ﹤0.01% |
199,100
-3,100
| -2% | -$55.2K |
|
1446
Alamo Group
ALG
$2.49B
| $3.55M | ﹤0.01% |
19,900
-200
| -1% | -$35.6K |
|
1447
Amicus Therapeutics
FOLD
$2.57B
| $3.54M | ﹤0.01% |
434,200
-3,300
| -0.8% | -$26.9K |
|
1448
Informatica
INFA
$7.57B
| $3.53M | ﹤0.01% |
202,500
+75,200
| +59% | +$1.31M |
|
1449
D-Wave Quantum
QBTS
$8.04B
| $3.53M | ﹤0.01% |
+464,800
| New | +$3.53M |
|
1450
MYR Group
MYRG
$2.82B
| $3.53M | ﹤0.01% |
31,200
-1,300
| -4% | -$147K |
|